Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Oaktree Acquisition Corp II Cl A
(NY:
OACB
)
N/A
UNCHANGED
Last Price
Updated: 7:00 PM EDT, Jun 15, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Oaktree Acquisition Corp II Cl A
Alvotech and Oaktree Acquisition Corp. II Announce Shareholder Approval of Business Combination
June 07, 2022
From
Alvotech Holdings S.A.
Via
Business Wire
Oaktree Acquisition Corp. II Announces Delisting of its Securities Effective and Conditional Upon Consummation of its Pending Business Combination with Alvotech
June 03, 2022
From
Oaktree Acquisition Corp. II
Via
Business Wire
Alvotech Clinical Study Results Demonstrate Therapeutic Equivalence between Biosimilar Candidate AVT04 and Reference Product Stelara®
May 24, 2022
From
Alvotech Holdings S.A.
Via
Business Wire
Alvotech Announces Positive Results from a Pharmacokinetic Similarity Study for AVT04, a Proposed Biosimilar to Stelara®
May 16, 2022
From
Alvotech Holdings S.A.
Via
Business Wire
Alvotech, Global Biotech Company, and Oaktree Acquisition Corp. II Announce June 7, 2022 Extraordinary General Meeting to Approve Business Combination
May 11, 2022
From
Alvotech Holdings S.A.
Via
Business Wire
Alvotech Improves Access to Capital and Streamlines Path to Expected Public Listing on NASDAQ Stock Exchange
April 19, 2022
From
Alvotech Holdings S.A.
Via
Business Wire
Alvotech and STADA Pave Way to Launching HUKYNDRA®(AVT02), a Citrate-free, High-concentration Biosimilar to Humira® by Resolving European Patent Dispute With AbbVie
April 06, 2022
From
Alvotech Holdings S.A.
Via
Business Wire
Alvotech Upsizes Oversubscribed PIPE Transaction to Approximately $175 Million
January 18, 2022
From
Alvotech Holdings S.A.
Via
Business Wire
Alvotech and Oaktree Acquisition Corp. II Announce Merger Agreement to Create a Leading Publicly-Traded Global Biopharmaceutical Company
December 07, 2021
From
Alvotech Holdings S.A.
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.